Clinical diagnostic criteria for cardiogenic shock should be based on pathophysiology

Petr Ostadal1

  • 1Department of Cardiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.

Insights

New diagnostic criteria are needed for cardiogenic shock, a condition of cardiac pump failure. Revised guidelines should focus on low cardiac output and tissue hypoperfusion, excluding hypovolemia for better patient targeting.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock involves cardiac pump failure leading to low cardiac output and tissue hypoperfusion.
  • Current diagnostic guidelines rely on hypotension and hypoperfusion signs, which are imperfect.
  • These criteria may not reliably differentiate cardiogenic shock from other shock types.

Purpose of the Study:

  • To highlight the limitations of current cardiogenic shock diagnostic criteria.
  • To propose revised diagnostic criteria for cardiogenic shock based on pathophysiology.
  • To improve the accuracy of cardiogenic shock diagnosis and patient selection for targeted therapies.

Main Methods:

  • Review of current guidelines and recent randomized clinical trials.
  • Analysis of the pathophysiology of cardiogenic shock.
  • Development of a revised definition incorporating objective biomarkers and exclusion of hypovolemia.

Main Results:

  • Current diagnostic criteria for cardiogenic shock are insufficient.
  • Proposed criteria include low cardiac output, objective hypoperfusion evidence, and absence of hypovolemia.
  • Accurate diagnosis is crucial for appropriate patient stratification.

Conclusions:

  • Revised diagnostic criteria for cardiogenic shock are urgently needed.
  • A pathophysiology-grounded definition will improve diagnostic accuracy.
  • Enhanced diagnostic precision will optimize patient selection for specific treatments.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
351
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
464
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
678